TiumBio grants Chiesi rights to develop TGF-β molecules to treat respiratory diseases

TiumBio Co. Ltd. (Seongnam, South Korea) granted Chiesi

Read the full 80 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE